Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!
Sep 26, 2018
Functional β-cell mass loss leads to the pathogenesis of type 1 diabetes mellitus (T1DM) and also adds to type 2 diabetes mellitus (T2DM). Genetically induced downregulation of Arx, a key transcription factor for glucagon-producing α-cell specification and phenotype, in α-cells converts them into insulin-producing β...
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
-Agonist.png "Toll-like Receptors Agonist")
Newsletter/Whitepaper